Mydot Mycophenolate Oral Suspension

Product Description

This medicine is contraindicated during pregnancy due to the risk of birth defects and miscarriage. It should not be advised in pregnant women unless there are no relevant alternatives and the potential benefits outweigh the risks. Women of birthing age are highly advised to use effective contraception while taking this tablet to prevent pregnancy. 

Live vaccines should not be administered while a person is taking a Mydot 1gm Oral Suspension due to reduced vaccine effectiveness and the risk of infection. Individuals taking this drug should not donate blood during treatment and at least six weeks after stopping treatment. It ensures that the medication has been adequately cleared from the body before donating blood.

It is generally advised not to take this medicine if you are allergic to the drug or any other ingredients. Inform your doctor of liver or heart disease before initiating the treatment. As this drug reduces the body's immune defences, it can increase the chance of skin cancer. Individuals must take precautions to limit their exposure to sunlight and ultraviolet (UV) light. 

Seek your doctor immediately if you develop any bruising under the skin, fever, unexplained tiredness, dizziness, yellowing of the skin or eyes, vision impairment, reduced urine output, or seizures after taking this medicine. Mydot 1gm Oral Suspension is an immunosuppressive medication. It may affect the infant's developing immune system and should be avoided in breastfeeding. In some cases, alternative medications with a more favourable safety profile during breastfeeding may be considered.